Database

Startups

Main Industry
Biotechnology
Founded Year
2023
Unified Business No.
94072060
Status
Active
Number of Employees
21
Total Paid-in Capital
580,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Exit Status
Emerging Stock Exchange(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.

Similar Companies

FORESEE PHARMACEUTICALS CO., LTD.

1. CAMCEVI 42 mg
2. CAMCEVI 21 mg
3. FP-025
4. FP-045
5. Aderamastat (FP-025) Phase 2 Study

CHO PHARMA INC.

1. CHOptimax™
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04

BIONET Therapeutics Corp.

At BIONET Therapeutics Corp., our focus is on regenerative medicinal products, Advanced tech-enabled research and development, exosomes, and gene/cell therapy.

Rock BioMedical, Inc.

Rock Bio’s Low-Sugar Universal Vaccine™ technology stems from pioneering glycoengineering research led by Professor Chi-Huey Wong and was recognized by IUPAC in 2023 as one of the Top 10 Emerging Technologies in Chemistry. This approach addresses viral im